US2013005953A1PendingUtilityA1
Readthrough Inducing Agent and Drug for Treating Genetic Disease Caused by Nonsense Mutation
Est. expiryFeb 3, 2030(~3.5 yrs left)· nominal 20-yr term from priority
Inventors:Ryoichi MatsudaMasataka ShiozukaAkira WagatsumaYoshikazu TakahashiDaishiro IkedaYoshiaki NonomuraMasafumi MatsuoAtsushi Nishida
A61P 35/00A61P 7/04A61P 3/06A61P 37/06A61P 7/00A61P 3/10A61P 5/14A61P 9/02A61P 37/02A61P 9/10A61P 43/00A61P 29/00A61P 3/04A61P 25/00A61P 25/16A61P 25/28A61P 27/02A61P 19/02A61P 21/04A61P 1/16A61P 21/00A61P 17/00A61P 13/12A61P 11/00A61P 19/00A61K 31/7036A61K 48/00C07H 15/234
40
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A readthrough inducing agent for inducing readthrough of a premature stop codon generated by nonsense mutations, the readthrough inducing agent comprising a compound having a structure expressed by the following Structural Formula (A), and a drug for treating a genetic disease caused by nonsense mutations, the drug comprising the readthrough inducing agent.
Claims
exact text as granted — not AI-modified1 . A readthrough inducing agent for inducing readthrough of a premature stop codon generated by nonsense mutations, the readthrough inducing agent comprising:
a compound having a structure expressed by the following Structural Formula (A):
2 . A drug for treating a genetic disease caused by nonsense mutations, the drug comprising:
a readthrough inducing agent for inducing readthrough of a premature stop codon generated by nonsense mutations, wherein the readthrough inducing agent comprises: a compound having a structure expressed by the following Structural Formula (A):
3 . The drug according to claim 2 , wherein the genetic disease caused by nonsense mutations is muscular dystrophy.Join the waitlist — get patent alerts
Track US2013005953A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.